The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Investigating peripheral blood biomarkers of immune checkpoint inhibitor associated fatigue.
 
Howard Liu Li
No Relationships to Disclose
 
Soren Charmsaz
No Relationships to Disclose
 
Stephanie Leigh Alden
No Relationships to Disclose
 
Madelena Brancati
No Relationships to Disclose
 
Aanika Warner
No Relationships to Disclose
 
Kabeer Munjal
No Relationships to Disclose
 
Hua-Ling Tsai
No Relationships to Disclose
 
Nicole E. Gross
No Relationships to Disclose
 
Christopher Thoburn
No Relationships to Disclose
 
Evan J. Lipson
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; CareDX; HUYA Bioscience International; Immunocore; Instil Bio; Merck; Nektar; Novartis; OncoSec; Pfizer; Rain Therapeutics; Regeneron; Replimune
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Regeneron (Inst); Sanofi (Inst)
 
Yasser Ged
Consulting or Advisory Role - AVEO; BostonGene; Bristol Myers Squibb; Eisai; Exelixis; Targeted Oncology; Targeted Oncology
 
Rachel Garonce-Hediger
Employment - F. Hoffmann LaRoche
Stock and Other Ownership Interests - F. Hoffmann LaRoche
Travel, Accommodations, Expenses - F. Hoffmann LaRoche
 
Sanjay Bansal
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Laura Tang
Employment - Genentech
Stock and Other Ownership Interests - Bayer; Exact Sciences (I); Genentech
Travel, Accommodations, Expenses - Genentech; Genentech
 
Elizabeth M. Jaffee
Stock and Other Ownership Interests - ABMETA Therapeutics; Adventris
Consulting or Advisory Role - Achilles Therapeutics; Dragonfly Therapeutics; Medically Home; Mestag Therapeutics; NeoTX; NEUVOGEN; SURGE Therapeutics
Research Funding - Breast Cancer Research Foundation; Bristol-Myers Squibb; Lucence Diagnostics; Roche
Patents, Royalties, Other Intellectual Property - I developed GVAX which is being tested in the clinics. It was licensed to Adoro Biotech. IF it becomes commercial I will have the potential to receive royalties. Also, I have received milestone payments yearly.
Other Relationship - Break Through Cancer; CPRIT; Parker Institute; Parker Institute
 
G Scott Chandler
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
Research Funding - Roche/Genentech
Patents, Royalties, Other Intellectual Property - Patent pending as co-inventor of novel biomarker work performed as Roche employee
Travel, Accommodations, Expenses - Roche/Genentech
 
Rajat Mohindra
Employment - Novartis (I); Roche
Stock and Other Ownership Interests - Novartis (I); Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Roche
 
Won Jin Ho
Honoraria - Exelixis; Standard BioTools
Research Funding - Circle Pharma; NeoTX; Sanofi
Patents, Royalties, Other Intellectual Property - Amgen; Rodeo Therapeutics
 
Mark Yarchoan
Leadership - Adventris Pharmaceuticals
Stock and Other Ownership Interests - Adventris Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Eisai; Exelixis; Genentech/Roche; Hepion Pharmaceuticals; Replimune
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Incyte (Inst); Merck (Inst)
(OPTIONAL) Uncompensated Relationships - Merck
 
Chester Kao
No Relationships to Disclose